This marks the fifth consecutive day of losses for Teladoc, with the stock falling roughly 16% over this period. The persistent selling without identifiable news suggests either ongoing institutional repositioning or broader concerns about the telehealth sector that haven't surfaced in public reporting. For context, the S&P 500 was essentially flat today, confirming this is company-specific weakness rather than market-driven.
This is a permanent link to this specific analysis (ID: 2504)
Back to Dashboard